The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic ...

Katie Thurston, the 34-year-old former Bachelorette star, is redefining life after a stage 4 breast cancer diagnosis that ...

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...

Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver ...

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

Metastatic means the cancer has spread from the prostate to other parts of the body, like the bones, liver, or lungs. This ...

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer Delcath Systems, Inc. (NASDAQ: DCTH), an ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...